These data therefore demonstrate that targeting p21 after senescent cells have developed and deposited SASP components in fibrotic tissue is an effective strategy to resolve many of the pathological changes associated with lung fibrosis. This evidence concerns the gene CDKN1A and pulmonary fibrosis.